Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-04-15Clinical Trial Update: The Role of 1.5-anhydro-D-glucitol as Clinical Biomarkers of Hypoglycemia in Patients With Diabetes
This clinical trial update evaluates whether 1.5-anhydro-D-glucitol can serve as a biomarker for hypoglycemia in people with type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Diabetes Lifestyle Assessment and Educational Tools [NA]
The document notes the completion of a clinical trial studying diabetes lifestyle assessment and educational tools for people with Type 2 Di…
-
FDA approval · 2016-04-14FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVOKAMET (canagliflozin and metformin hydrochloride) from Janssen Pharmaceuticals, Inc., gr…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM) [Phase 4]
Phase 4 trial comparing ticagrelor and clopidogrel in patients with coronary artery disease and type 2 diabetes mellitus; current status is …
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Laparoscopic Bariatric Surgery to Treat Type 2 Diabetes in Obese Patients [NA]
A clinical trial evaluating laparoscopic bariatric surgery as a treatment for type 2 diabetes in obese patients has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-04-14Clinical Trial Update: Role of Interrupting Sedentary Time in Management of Type-2 Diabetes [NA]
This clinical trial update discusses whether interrupting sedentary time can improve management of Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 trial evaluating TAK-875 (fasiglifam) in adults with Type 2 diabetes mellitus has completed, reporting on efficacy and safety. The u…
-
CLINICAL_TRIALS research · 2016-04-13Clinical Trial Update: Boosting Emotions & Happiness in Outpatients Living With Diabetes [NA]
This clinical trial update reports the completion of a Massachusetts General Hospital study evaluating a psychosocial intervention to boost …
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Glucose Response, Excursions And Treatment (GREAT) Study [NA]
The Glucose Response, Excursions And Treatment (GREAT) study investigating glucose variability in Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes [Phase 4]
Phase 4 trial assessing whether Exenatide affects liver fat content in people with Type 2 Diabetes Mellitus; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating the safety and efficacy of dapagliflozin as part of triple therapy for type 2 diabetes, with results posted in 2016…
-
CLINICAL_TRIALS research · 2016-04-11Clinical Trial Update: IMS® DIAREG Diabetes Registry - Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus
This document provides an update on the IMS DIAREG Diabetes Registry, a prospective registry of patients with Type 2 Diabetes Mellitus, spon…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Assessing the Effectiveness of a Weight Watchers-based Lifestyle Intervention for the Primary Prevention of Type 2 Diabetes [NA]
A completed clinical trial evaluated a Weight Watchers-based lifestyle program for the primary prevention of Type 2 diabetes in individuals …
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Chromium and Insulin Action [Phase 4]
This Phase 4 trial investigated chromium supplementation and its effect on insulin action in people with type 2 diabetes mellitus and has co…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes [Phase 4]
Phase 4 trial evaluating chromium picolinate for improving insulin sensitivity in Type 2 diabetes has completed.
-
CLINICAL_TRIALS withdrawal · 2016-04-08Clinical Trial Update: Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes [Phase 1]
Phase 1 trial of collagen scaffolds loaded with human umbilical cord mesenchymal stem cells for erectile function in men with diabetes has b…
-
FDA approval · 2016-04-07FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
The FDA approved a supplemental application for AFREZZA (insulin human) from Mannkind Corporation.
-
CLINICAL_TRIALS trial_result · 2016-04-07Clinical Trial Update: Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM [Phase 1, Phase 2]
A clinical trial update on Met DR in Type 2 Diabetes Mellitus patients evaluating plasma glucose and pharmacokinetics in Phase 1/Phase 2. Th…
-
CLINICAL_TRIALS trial_result · 2016-04-07Clinical Trial Update: A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog® Mix 75/25 in Subjects With Type 2 Diabetes [Phase 2]
A Phase 2 study comparing BIOD 531 to Humalog Mix 75/25 for Type 2 diabetes has been suspended.
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents [Phase 4]
Phase 4 clinical trial assessing blood pressure reduction, safety, and tolerability of canagliflozin in adults with type 2 diabetes and hype…
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Evolution of Effectiveness of Diabetes Medical Care in Russia
This record notes the completion of a clinical trial in Moscow assessing the evolution of effectiveness of diabetes medical care.
-
FDA approval · 2016-04-05FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2016-04-05FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for metformin hydrochloride from Granules Pharmaceuticals Inc., authorizing an additional formulatio…
-
FDA approval · 2016-04-05FDA Approved: ALOGLIPTIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for ALOGLIPTIN filed by Padagis Israel Pharmaceuticals Ltd, authorizing changes to an existing alogl…
-
FDA approval · 2016-04-05FDA Approved: KAZANO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Kazano (alogliptin and metformin hydrochloride) from Takeda Pharmaceuticals America, Inc.